Stay updated on GSK2857916 & Pembrolizumab in RRMM Clinical Trial
Sign up to get notified when there's something new on the GSK2857916 & Pembrolizumab in RRMM Clinical Trial page.

Latest updates to the GSK2857916 & Pembrolizumab in RRMM Clinical Trial page
- Check4 days agoChange DetectedThe history now includes a note that the study is no longer looking for participants and adds the revision tag v3.6.0, while removing the previous revision v3.5.5.SummaryDifference0.3%

- Check12 days agoChange DetectedThe study history now shows Revision: v3.5.5 added and Revision: v3.5.4 removed, updating the page's version trail.SummaryDifference0.1%

- Check19 days agoNo Change Detected
- Check26 days agoNo Change Detected
- Check33 days agoChange DetectedThe history now includes Revision: v3.5.4, replacing Revision: v3.5.3; this indicates a small software update for ClinicalTrials.gov without altering study details.SummaryDifference0.1%

- Check54 days agoChange DetectedThe page’s displayed software/interface revision updates from version v3.5.2 to v3.5.3, without changing the underlying study record content.SummaryDifference0.1%

- Check61 days agoChange DetectedAdded Revision: v3.5.2; Deleted Revision: v3.5.0 from the history.SummaryDifference0.1%

- Check90 days agoChange DetectedRevision v3.5.0 was added to the Record History and revision v3.4.3 was removed.SummaryDifference0.1%

Stay in the know with updates to GSK2857916 & Pembrolizumab in RRMM Clinical Trial
Enter your email address, and we'll notify you when there's something new on the GSK2857916 & Pembrolizumab in RRMM Clinical Trial page.